Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14356/2579
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPrajapati, Dipanker-
dc.date.accessioned2024-12-29T07:48:43Z-
dc.date.available2024-12-29T07:48:43Z-
dc.date.issued2024-
dc.identifier.citation@NHRC Libraryen_US
dc.identifier.urihttps://hdl.handle.net/20.500.14356/2579-
dc.descriptionProvincial Grant Report.en_US
dc.description.abstractNAen_US
dc.language.isoen_USen_US
dc.publisherNepal Health Research Council (NHRC), Ram Shah Path, Kathmandu, Nepalen_US
dc.subjecta randomized control studyen_US
dc.subjectwarfarin versus rivaroxabanen_US
dc.subjectpost myocardial infarction left ventricular thrombusen_US
dc.titleComparison of warfarin versus rivaroxaban in management of post myocardial infarction left ventricular thrombus in a tertiary cardiac centre of Nepal: a randomized control studyen_US
dc.typeResearch reporten_US
Appears in Collections:Provincial Grant Reports

Files in This Item:
File Description SizeFormat 
RES001203_PRA_2024.pdfFull Report. Download.1.96 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.